All articles by Staff Writer
Staff Writer
Attend the Healthcare Innovation Summit Africa 2023
As technology continues to transform and disrupt every sector, the health sector is no exception. Digital innovation is having a tremendous impact on the healthcare industry from the way individuals gain access to services, to the breakthrough development of new technology that is radically transforming diagnostic procedures.
deepc Establishes MONAI Compatibility, Strengthening Its Commitment to Open-Source Collaboration and Global Healthcare Transformation
deepc, a leading MedTech company, aligns strategically with MONAI, the Medical Open Network for Artificial Intelligence. A community-driven open-source framework co-founded by NVIDIA and King’s College London, MONAI aims to advance healthcare through medical imaging. By ensuring MONAI compatibility on its platform, deepcOS, deepc emphasizes commitment to open-source AI, interoperability, and global AI development standards.
DxVx, plans to make a license-in agreement of OVM-200 and conduct clinical trials in Asia
DxVx announces today that it will conduct its own clinical trials of OVM-200, an anti-cancer vaccine from Oxford Vacmedix(OVM) by license-in agreement and develop further with its own new drug development knowledge. Currently, the vaccine has completed a Phase 1a clinical trial in the first half of this year and is expected to start a Phase 1b trial soon.
Trillium Health Partners to become first in Canada to deploy AI in diagnostic imaging using Sectra Amplifier Services
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) helps Trillium Health Partners (THP) in Canada adopt AI technology with new AI-as-a-service agreement via Sectra Amplifier Services. This will enable THP to introduce AI-powered workflows in its diagnostic imaging department, which will help identify serious health conditions sooner, allowing for earlier intervention and better health outcomes.
Healing innovation
Chronic wounds are a major challenge worldwide. This from an economic standpoint – as managing them expends time and resources – and from a patient outcome perspective, as wounds that aren’t managed effectively can lead to significant morbidity and mortality. Professor Joachim Dissemond, MD, Department of Dermatology, Venerology and Allergology, University of Essen, Germany, is one of several academics who believe bringing more standardisation to the care of chronic wounds will improve their management, and outcomes. He tells Practical Patient Care about the M.O.I.S.T. concept developed by him and his colleagues and how it improves upon the current framework for treating wounds.
QIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro Kit for improved sample processing and RNA isolation
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its sample technologies portfolio with the introduction of two new products aimed at supporting researchers in managing diverse materials such as bone, tissue and soil samples:
Medica And Compamed: Medical Technology Business Benefits From The Strong International Visitor Response
High decision-maker ratio, unique variety of new products and a top-class supporting program
Roche’s MS test scores FDA breakthrough device designation
Roche’s Elecsys neurofilament light chain (NfL) test is used for detecting disease activity in multiple sclerosis.
QIAGEN launches new QIAcuity digital PCR kits and updated software to expand use by biopharma and food safety customers
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of three new kits for use on its QIAcuity systems and a major new software update designed to expand the portfolio of applications for use of digital PCR technology in areas like cell and gene therapies, DNA and RNA quantification, as well as food and pharmaceuticals safety:
Deep Bio Joins CancerX to Revolutionize Cancer Diagnosis and Prognosis with AI Expertise
Deep Bio, a leading AI healthcare company specializing in deep learning and cancer pathology, is proud to announce its participation in the groundbreaking CancerX initiative, a public-private partnership unveiled earlier this year as part of the White House Cancer Moonshot program. This strategic partnership marks a significant milestone in the company’s mission to transform the landscape of cancer diagnosis and prognosis.